Hormone-positive breast cancer often stops responding to treatment quietly — the cancer changes before a scan ever shows it. In this episode, we break down a new drug and a simple blood test that together are changing how oncologists catch that shift and respond to it.
In this episode, you'll learn:
Why aromatase inhibitors eventually stop working for some patients
What a liquid biopsy can detect that a scan can't
How camizestrant (Etcamah) works differently from older hormone therapies
What the latest clinical trial data actually showed
The question worth asking your oncologist at your next visit
This one's worth watching if hormone-driven breast cancer is part of your story, or someone you love's.
Disclaimer: The information provided in this podcast is for educational and informational purposes only, and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard or read in this podcast or on this channel. Reliance on any information provided by Dr. Jay Chaplin or Elevating Cancer Treatment is solely at your own risk. Dr. Jay Chaplin is a scientist and drug developer, not a medical doctor providing patient care. The content presented here reflects general scientific understanding and research, and may not be applicable to your individual health circumstances. Individual medical conditions and treatments vary, and no two situations are exactly alike. Always consult with your personal healthcare provider before making any decisions about your health or treatment plan.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Jay Chaplin. Innehållet i podden är skapat av Dr. Jay Chaplin och inte av,
eller tillsammans med, Poddtoppen.
